Publication | Open Access
A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infinium 450 k DNA methylation data
1.8K
Citations
21
References
2012
Year
The Illumina Infinium 450 k DNA methylation BeadChip is widely used for EWAS, but its two probe designs have markedly different methylation distributions and dynamic ranges, potentially biasing analyses. The study aims to develop a statistical method to adjust for the probe design bias in 450 k data. BMIQ applies a three‑state beta‑mixture model to classify probes, transforms probabilities into quantiles, and then dilates type 2 probe beta‑values to match the type 1 distribution while preserving monotonicity. BMIQ reduces technical variation and type 2 bias, eliminates type 1 enrichment bias, and outperforms two competing methods on cell‑line, fresh‑frozen, and paraffin‑embedded tumor samples. BMIQ is freely available at http://code.google.com/p/bmiq/ and contact is a.teschendorff@ucl.ac.uk.
Abstract Motivation: The Illumina Infinium 450 k DNA Methylation Beadchip is a prime candidate technology for Epigenome-Wide Association Studies (EWAS). However, a difficulty associated with these beadarrays is that probes come in two different designs, characterized by widely different DNA methylation distributions and dynamic range, which may bias downstream analyses. A key statistical issue is therefore how best to adjust for the two different probe designs. Results: Here we propose a novel model-based intra-array normalization strategy for 450 k data, called BMIQ (Beta MIxture Quantile dilation), to adjust the beta-values of type2 design probes into a statistical distribution characteristic of type1 probes. The strategy involves application of a three-state beta-mixture model to assign probes to methylation states, subsequent transformation of probabilities into quantiles and finally a methylation-dependent dilation transformation to preserve the monotonicity and continuity of the data. We validate our method on cell-line data, fresh frozen and paraffin-embedded tumour tissue samples and demonstrate that BMIQ compares favourably with two competing methods. Specifically, we show that BMIQ improves the robustness of the normalization procedure, reduces the technical variation and bias of type2 probe values and successfully eliminates the type1 enrichment bias caused by the lower dynamic range of type2 probes. BMIQ will be useful as a preprocessing step for any study using the Illumina Infinium 450 k platform. Availability: BMIQ is freely available from http://code.google.com/p/bmiq/. Contact: a.teschendorff@ucl.ac.uk Supplementary information: Supplementary data are available at Bioinformatics online
| Year | Citations | |
|---|---|---|
Page 1
Page 1